Pericardiocentesis with extended catheter drainage: An effective therapy

被引:30
作者
Buchanan, CL
Sullivan, VV
Lampman, R
Kulkarni, MG
机构
[1] St Joseph Mercy Hosp, Dept Surg, Ann Arbor, MI 48106 USA
[2] Foote Hosp, Dept Surg, Jackson, MI USA
关键词
D O I
10.1016/S0003-4975(03)00666-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The most effective method for managing pericardial effusions has yet to be identified. This study evaluates the efficacy and safety of echocardiographic guided placement of indwelling catheters into the pericardial space. Methods. This study consists of a 5-year retrospective chart review of consecutive patients coded with benign or malignant pericardial effusions who presented for drainage procedures to a single surgeon at a 260-bed hospital. Complication, recurrence, and survival rates were studied. Results. Between January 1996 and August 2001, a total of 29 pericardial drainage procedures were performed; eight of those also underwent talc sclerosis. Mean follow-up was 16 months. Three patients (10%) required conversion to thoracotomy; of those remaining, 25 of the 26 procedures were performed under local anesthesia with intravenous sedation. The identified etiologies for pericardial effusions were malignancy (76%), idiopathic (14%), postcoronary artery bypass grafting procedure (3%), viral pericarditis (3%), and uremia (3%). Echocardiographic features of tamponade were documented in 72%. Mean +/- SEM length of postprocedure in-hospital stay was 6.7 +/- 0.82 days. The overall complication rate was 10% (pneumothorax and cardiac injury). Recurrence rate within 30 days was 7%. Thirty-day mortality was 21%, and more than 90-day survival was 72%. Conclusions. Pericardiocentesis with extended catheter drainage is a safe treatment for management of clinically significant, malignant and benign, pericardial effusions and can be performed effectively under local anesthesia with intravenous sedation. (C) 2003 by The Society of Thoracic Surgeons.
引用
收藏
页码:817 / 820
页数:4
相关论文
共 9 条
[1]   Pericardial effusion: Subxiphoid pericardiostomy versus percutaneous catheter drainage [J].
Allen, KB ;
Faber, LP ;
Warren, WH ;
Shaar, CJ .
ANNALS OF THORACIC SURGERY, 1999, 67 (02) :437-440
[2]   Pericardiocentesis and intrapericardial sclerosis: Effective therapy for malignant pericardial effusions [J].
Girardi, LN ;
Ginsberg, RJ ;
Burt, ME .
ANNALS OF THORACIC SURGERY, 1997, 64 (05) :1422-1427
[3]   PERICARDIAL WINDOW FOR MALIGNANT PERICARDIAL-EFFUSION [J].
HANKINS, JR ;
SATTERFIELD, JR ;
AISNER, J ;
WIERNIK, PH ;
MCLAUGHLIN, JS .
ANNALS OF THORACIC SURGERY, 1980, 30 (05) :465-471
[4]  
Larrey EL, 1829, CLIN CHIR, V36, P303
[5]  
PARK JS, 1991, CANCER, V67, P76, DOI 10.1002/1097-0142(19910101)67:1<76::AID-CNCR2820670115>3.0.CO
[6]  
2-6
[7]  
Salem K, 1999, CAN J CARDIOL, V15, P1251
[8]   TREATMENT OF MALIGNANT PERICARDIAL-EFFUSION [J].
VAITKUS, PT ;
HERRMANN, HC ;
LEWINTER, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (01) :59-64
[9]   RISK OF PERICARDIOCENTESIS [J].
WONG, B ;
MURPHY, J ;
CHANG, CJ ;
HASSENEIN, K ;
DUNN, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (06) :1110-1114